Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)

Detalles Bibliográficos
Autores principales: Takada, Kazuki, Takamori, Shinkichi, Miura, Naoko, Shikada, Yasunori, Shimokawa, Mototsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387225/
https://www.ncbi.nlm.nih.gov/pubmed/34507831
http://dx.doi.org/10.1016/j.ejca.2021.07.046
_version_ 1783742418404769792
author Takada, Kazuki
Takamori, Shinkichi
Miura, Naoko
Shikada, Yasunori
Shimokawa, Mototsugu
author_facet Takada, Kazuki
Takamori, Shinkichi
Miura, Naoko
Shikada, Yasunori
Shimokawa, Mototsugu
author_sort Takada, Kazuki
collection PubMed
description
format Online
Article
Text
id pubmed-8387225
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-83872252021-08-26 Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study) Takada, Kazuki Takamori, Shinkichi Miura, Naoko Shikada, Yasunori Shimokawa, Mototsugu Eur J Cancer Letter to the Editor Elsevier Ltd. 2021-11 2021-08-26 /pmc/articles/PMC8387225/ /pubmed/34507831 http://dx.doi.org/10.1016/j.ejca.2021.07.046 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Takada, Kazuki
Takamori, Shinkichi
Miura, Naoko
Shikada, Yasunori
Shimokawa, Mototsugu
Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)
title Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)
title_full Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)
title_fullStr Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)
title_full_unstemmed Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)
title_short Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)
title_sort re: covid-19 in patients with neuroendocrine neoplasms: preliminary results of a worldwide survey (the intensive study)
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387225/
https://www.ncbi.nlm.nih.gov/pubmed/34507831
http://dx.doi.org/10.1016/j.ejca.2021.07.046
work_keys_str_mv AT takadakazuki recovid19inpatientswithneuroendocrineneoplasmspreliminaryresultsofaworldwidesurveytheintensivestudy
AT takamorishinkichi recovid19inpatientswithneuroendocrineneoplasmspreliminaryresultsofaworldwidesurveytheintensivestudy
AT miuranaoko recovid19inpatientswithneuroendocrineneoplasmspreliminaryresultsofaworldwidesurveytheintensivestudy
AT shikadayasunori recovid19inpatientswithneuroendocrineneoplasmspreliminaryresultsofaworldwidesurveytheintensivestudy
AT shimokawamototsugu recovid19inpatientswithneuroendocrineneoplasmspreliminaryresultsofaworldwidesurveytheintensivestudy

Ejemplares similares